New York City-based Memorial Sloan Kettering Cancer Center ended the first six months of 2019 with higher revenue and operating income than in the same period a year earlier, according to ...

Oncology hospital Memorial Sloan Kettering recorded $28 million in gains during the first quarter of 2024, thanks to surges in patient services such as radiology treatments, financial documents show.

Memorial Sloan Kettering had a 1.4% operating margin during that time period. The cancer center’s expenses rose 9% in the second quarter, totaling $1.9 billion.

Memorial Sloan Kettering Cancer Center in New York City has asked one of its executives to turn over to the hospital the nearly $1.4 million stake in a biotech company he received for representing ...

Hospital officials also instituted policy changes to limit the ways in which its top executives and leading researchers could profit from work developed at Memorial Sloan Kettering, which admits ...

Carrie Regan of Pine Bush, a Memorial Sloan Kettering Cancer Center patient, hailed the Dec. 23, 2024 deal for in-network coverage between Anthem Blue Cross Blue Shield and MSK. The teacher called ...

In the two years since Memorial Sloan Kettering Cancer Center (MSK) announced plans for a new $2 billion facility on the Upper East Side, the illness remains a growing threat.. To prepare for what is ...

Tuesday morning, the nation’s largest insurance company, UnitedHealthcare and Memorial Sloan Kettering Cancer Center ...

Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Andrea Cercek Named to the Inaugural 2024 TIME100 Health List Andrea Cercek, MD , gastrointestinal ...

Fighting cancer is a worthy endeavor, and Memorial Sloan Kettering is quite good at it. But its expertise does not give the world-renowned nonprofit cancer treatment center carte blanche to engage ...

When it comes to cancer metastasis, it takes two to tango. That was one of the key findings of a new study led by researchers at Memorial Sloan Kettering Cancer Center (MSK): The TGF-beta and RAS ...

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...